Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-1,849,867
Put/Call ratio
0%
SEC-reported price per share
$1.16
Number of holders
69
Value change
-$2,103,479
Number of buys
31
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,227,200

Security key

00509G209

Report period

Q2 2025

Institutions

69

Top holders

10

Ownership snapshot

Top reported holders of ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sands Capital Alternative...
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 5.6% 13D/G row: Sands Capital Alternatives, LLC Showing 1-6 of 15 holder rows.

Quick read

Sands Capital Alternatives, LLC leads the comparable SEC ownership view at 5.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sands Capital Alternatives, LLC's linked filing trail.
Comparable ownership Top 5
Sands Capital Alternatives, LLC 5.6%
James B. Murray Jr. 5%
RA CAPITAL MANAGEMENT, L.P. 21%
FRANKLIN RESOURCES INC 4.4%
BlackRock, Inc. 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sands Capital Alternatives, LLC
13D/G 13F
Company
5.6%
$3,861,295
3,417,075 shares
$0 30 Jun 2025
James B. Murray Jr.
13D/G
5%
$9,425,650
3,611,360 shares
$0 04 Apr 2025
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
21%
$16,425,269
14,932,063 shares
31 Mar 2025
FRANKLIN RESOURCES INC
13F
Company
13F
4.4%
$3,456,133
3,141,939 shares
31 Mar 2025
BlackRock, Inc.
13F
Company
13F
3.2%
$2,564,155
2,331,049 shares
31 Mar 2025
FMR LLC
13F
Company
13F
2.8%
$2,228,185
2,025,623 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
69
Shares
37,585,884
Rows available
69
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
79
Q2 2025 holders
69
Holder diff
-10
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .